Display options
Cite
Mohamed M, Fernando R. Diagnostic and therapeutic quandaries in a patient with primary hepatic lymphoma and concurrent hepatitis C infection. Indian J Hematol Blood Transfus. 2014;30:394-7doi: 10.1007/s12288-014-0431-z.
Mohamed, M., & Fernando, R. (2014). Diagnostic and therapeutic quandaries in a patient with primary hepatic lymphoma and concurrent hepatitis C infection. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 30394-7. https://doi.org/10.1007/s12288-014-0431-z
Mohamed, Muhajir, and Fernando, Ruchira. "Diagnostic and therapeutic quandaries in a patient with primary hepatic lymphoma and concurrent hepatitis C infection." Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion vol. 30 (2014): 394-7. doi: https://doi.org/10.1007/s12288-014-0431-z
Mohamed M, Fernando R. Diagnostic and therapeutic quandaries in a patient with primary hepatic lymphoma and concurrent hepatitis C infection. Indian J Hematol Blood Transfus. 2014 Sep;30:394-7. doi: 10.1007/s12288-014-0431-z. Epub 2014 Jul 16. PMID: 25332629; PMCID: PMC4192212.
Copy Download .nbib Format: NLM
Share it on

Indian J Hematol Blood Transfus. 2014 Sep;30:394-7. doi: 10.1007/s12288-014-0431-z. Epub 2014 Jul 16.

Diagnostic and therapeutic quandaries in a patient with primary hepatic lymphoma and concurrent hepatitis C infection.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Muhajir Mohamed, Ruchira Fernando

Affiliations

  1. Haematology Department, Launceston General Hospital, Launceston, TAS Australia ; Launceston Clinical School, University of Tasmania, Launceston, TAS Australia.
  2. Pathology Department, Launceston General Hospital, Launceston, TAS Australia.

PMID: 25332629 PMCID: PMC4192212 DOI: 10.1007/s12288-014-0431-z

Abstract

Primary hepatic lymphoma (PHL) is a very rare sub-type of non-Hodgkin's lymphoma and hepatitis C infection may be a contributory factor. The association of hepatitis C infection and PHL causes difficulties in management since safety of rituximab in such situations is unclear due to lack of evidence. The role of anti-viral therapy in combination with chemotherapy is also uncertain. We describe the diagnostic and therapeutic challenges posed by a patient who was diagnosed with PHL and concurrent hepatitis C infection.

Keywords: Hepatitis C; Primary hepatic lymphoma

References

  1. Virchows Arch. 2012 Apr;460(4):379-87 - PubMed
  2. J Hepatol. 2008 Oct;49(4):557-63 - PubMed
  3. Hepatology. 2003 Apr;37(4):781-7 - PubMed
  4. Blood. 2010 Dec 9;116(24):5081-2 - PubMed
  5. J Clin Oncol. 2010 Dec 1;28(34):5097-100 - PubMed
  6. Blood. 2010 Dec 9;116(24):5119-25 - PubMed
  7. Leuk Lymphoma. 2002 Apr;43(4):747-51 - PubMed
  8. Ann Oncol. 2003 Sep;14(9):1341-5 - PubMed
  9. Ann Oncol. 2006 Sep;17(9):1434-40 - PubMed
  10. World J Radiol. 2012 Feb 28;4(2):53-7 - PubMed
  11. Int J Cancer. 2004 Aug 10;111(1):1-8 - PubMed
  12. JAMA. 2007 May 9;297(18):2010-7 - PubMed

Publication Types